如懿传

兴城市海洋与渔业局举办海洋与渔业安全生产培训班_我的网站

一 |     《日报》全媒体记者 王野报道          　　6月15日上午，为更好地普及并提高渔业船员的安全生产意识，在市海洋与渔业局指导下，兴城市海洋与渔业局在兴城海浪屿假日酒店举办海洋与渔业安全生产培训班。    (ECNS) -- China's pharmaceutical industry accelerated innovation in the first half of this year, with domestic companies steadily improving their R&D capabilities and growth momentum continuing to strengthen, data showed.    China's first broad-spectrum targeted anticancer drug entered clinical use at major hospitals across the country this year. It took only eight months to go from submission to market approval.    A total of 38 innovative drugs were approved for marketing in China in the first half, of which 31 were developed domestically, more than 80% of the total. Eleven drugs featuring new targets or new mechanisms were all developed independently by domestic companies, producing a number of world-first innovations. By the end of 2025, China had 4,751 innovative drugs under development, one-third of the global total and the largest pipeline of any country.    Behind this concentration of results lies a steadily strengthening industrial base. China has a complete pharmaceutical supply chain. It is not only the world's largest producer of active pharmaceutical ingredients but has also built a production system covering every pharmaceutical category.    This year, digital, intelligent, and green technologies have driven the industry's transformation and upgrading.     At a biopharmaceutical company in Shanxi Province, a newly built AI-powered bio-computing center can identify the structures of millions of protein functional domains in a short time, screening out ineffective molecules directly.    To date, China has supported 21 pharmaceutical firms in building excellent-level smart factories and has cultivated more than 300 green factories. In the first half, the added value of pharmaceutical enterprises above the designated scale grew 6.4% year on year, and exports held strong.    The world's first chemotherapy-sparing drug for gastric cancer, launched this year, had already earned overseas revenue through licensing deals before it reached the market, and is now exported to multiple countries and regions.    In the first half, the total value of China's innovative drug out-licensing deals reached $110 billion, the industry's export delivery value grew 9% year on year, and high-value-added products made up nearly 20% of the total.        (By Tang Yuxian)                    。                             　　参加本次培训班的人员有市和兴城市渔业执法队的相关部门负责人以及来自兴城市各沿海乡镇涉海渔业船员共130余人。本次渔业安全生产培训时间正值伏季休渔期间，兴城属地各沿海乡镇渔业船舶均已按政府要求回港休渔或上坞维修，渔业船员正处于闲暇时，这个时候举办渔业安全生产培训班时间非常适宜，通过举办渔业安全生产培训让广大渔业船员提高安全生产意识，加强渔业安全生产技能，对我市渔业安全生产工作可谓意义重大。                                 　　据了解，按照市海洋与渔业局统一部署，海洋与安全生产培训班将在沿海县区陆续开班培训。                   　　《日报》全媒体记者 王野 摄。

Current article:http://rnq2sn.shouyouxumianpouluanteng.shop/r24/20260826/5507705.html

Published on:20:20:02